February 22, 2019 by Chain Drug Review
Ben Bulkley, EnvisionRxOptions, John Standley, Rite Aid Corp.
Leading Headlines, Pharmacy, Retail News
CAMP HILL, Pa.— Rite Aid Corp. announced that Ben Bulkley, an established executive with more than 20 years’ experience in health care and technology, has been named chief executive officer of EnvisionRxOptions, a pharmacy benefit management (PBM) company and wholly owned subsidiary of Rite Aid. Bulkley will report to Rite Aid CEO John Standley. Bulkley
February 19, 2019 by Chain Drug Review
Allen McClard, Bill Renz, GNC, Rite Aid Corp.
Featured Articles, Leading Headlines, Retail News, Supplier News
CAMP HILL, Pa. – Rite Aid Corp. and GNC announced Tuesday an agreement which extends their partnership through 2022. Rite Aid and GNC have had an exclusive partnership in the chain drug channel since December 1998. “Our more than 20-year partnership with GNC has provided Rite Aid with a key point of differentiation in the
January 25, 2019 by Chain Drug Review
New York Stock Exchange (NYSE), Rite Aid Corp.
Business, Leading Headlines, Retail News
CAMP HILL, PA – Rite Aid Corp. announced today that its board of directors has approved a reverse stock split of the company’s common stock. The reverse stock split is intended to enable Rite Aid to regain full compliance with the New York Stock Exchange (NYSE) listing rules. The reverse stock split is subject to
December 19, 2018 by Chain Drug Review
Brian Tyler, harmaceutical sourcing and distribution partnership, John Standley, McKesson Corp., Rite Aid Corp.
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
CAMP HILL, Pa. – Rite Aid Corp. and McKesson Corp. announced an agreement to key terms that will continue the companies’ pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029. Rite
December 18, 2018 by Chain Drug Review
Darren Karst, Justin Mennen, Rite Aid Corp., technology and information
Featured Articles, Leading Headlines, Retail News, Technology
CAMP HILL, Pa. — Rite Aid Corp. announced today that Justin Mennen, a seasoned technology and digital leader with more than 20 years of technology leadership experience, has been named Rite Aid’s senior vice president and chief information officer. In this position, Mennen will be responsible for all aspects of the company’s technology and information
August 8, 2018 by Chain Drug Review
Albertsons Cos., Albertsons-Rite Aid merger, John Standley, Rite Aid Corp.
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. – Rite Aid Corp. announced that it has mutually agreed with Albertsons Cos. to terminate their previously announced merger agreement. “While we believed in the merits of the combination with Albertsons, we have heard the views expressed by our stockholders and are committed to moving forward and executing our strategic plan as
August 6, 2018 by Chain Drug Review
Albertsons Cos., Albertsons-Rite Aid merger, Rite Aid Corp.
News
CAMP HILL, Pa. and BOISE, Idaho – Rite Aid Corp. and Albertsons Cos. announced that, in connection with the pending merger between Albertsons and Rite Aid, the election deadline for holders of shares of Rite Aid common stock, former service providers that are holders of Rite Aid restricted stock units and holders of Rite Aid
July 20, 2018 by Chain Drug Review
InTouch Health, Jocelyn Konrad, Joseph DeVivo, Rite Aid Corp., telehealth systems
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
SANTA BARBARA, Calif.– InTouch Health, a leading enterprise telehealth platform and Rite Aid Corp., have announced that they have signed a letter of intent to explore new ways to connect patients with health care providers and expand access to care. InTouch Health will leverage its InTouch Operating System, which powers telehealth programs at many of
June 26, 2018 by Chain Drug Review
Albertsons-Rite Aid merger, Rite Aid Corp.
Business, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. today announced that the registration statement on Form S-4, in connection with its proposed merger with Albertsons Cos., has been declared effective by the U.S. Securities and Exchange Commission (SEC). In connection with the definitive proxy statement/prospectus, Rite Aid issued a letter to shareholders detailing the merits of
January 23, 2017 by Chain Drug Review
Dedra Castle, Ken Black, Rite Aid Corp.
Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. has promoted Ken Black to senior vice president and chief human resources officer. He succeeds Dedra Castle, who is leaving the company for personal health reasons. “On behalf of the entire Rite Aid team, I thank Dedra for her many significant contributions to our company,” Rite Aid chairman
December 20, 2016 by Chain Drug Review
Fred’s Inc., Rite Aid Corp., Walgreens Boots Alliance Inc., WBA
Featured Articles, Leading Headlines, News, Retail News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have entered into an agreement to sell 865 Rite Aid stores and certain assets related to store operations to Fred’s Inc. for $950 million. The all-cash transaction, announced Tuesday, is subject to Federal Trade Commission approval, as well as the completion of the
June 9, 2016 by Chain Drug Review
Alex Gourlay, Ornella Barra, Rite Aid Corp., Walgreens Boots Alliance Inc., WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Top Walgreens Boots Alliance (WBA) executives Alex Gourlay and Ornella Barra have been appointed as co-chief operating officers as part of a realignment of the company’s senior management team. WBA said Thursday that the naming of Gourlay and Barra as co-COOs will help streamline the management of its global operations, which have
July 2, 2015 by Chain Drug Review
June, Rite Aid Corp., same-store sales
Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. posted a 2.4% same-store sales gain for June. Front-end comparable-store sales increased 0.3% over the prior-year period. Pharmacy same-store sales, which included a negative impact from new generic introductions of about 226 basis points, increased 3.4%. Prescription count at comparable stores increased 0.2%. Total sales for the four-week